Formulation Development
Curia Supports Replicate Bioscience’s Phase 1 Clinical Trial of Novel Next-Generation RNA Vaccine
Supply of drug substance manufactured under cGMP supports first-in-human clinical study for RBI-4000 novel self-replicating RNA (srRNA)….
KBI Biopharma Expands Global Portfolio With Launch of SUREmAb for Faster Monoclonal Antibody Development & Manufacturing
KBI Biopharma, Inc., a JSR Life Sciences company, recently announced the launch of SUREmAb, an offering built on the robustness of KBI’s SUREtechnology Platform, that…
Salipro Biotech Enters Research Collaboration With Sumitomo Pharma to Advance Drug Discovery Program
Salipro Biotech AB recently announced that it has entered into a research collaboration with Sumitomo Pharma Co., Ltd. to reveal the mechanism of action and…
Spinogenix Awarded $3-Million NIH Grant to Support Continued Development of the First Synaptic Regenerative Therapeutic for Alzheimer’s Disease
Spinogenix, Inc. recently announced a second grant award by the National Institute of Health (NIH). The new $3- million grant titled Development of a Novel,…
Lisata Therapeutics Announces First Patient Treated in BOLSTER Trial Novel Tumor-Targeting & Penetrating Peptide in Patients With Advanced Solid Tumors
Lisata Therapeutics, Inc. recently announced treatment of the first patient in the head and neck squamous cell carcinoma cohort of the BOLSTER trial, by Dr.…
Black Diamond Therapeutics Announces First Patients Dosed in Phase 1 Clinical Trial Expansion Cohorts Evaluating BDTX-1535 in Patients With Intrinsic Driver & Acquired Resistance EGFR Mutation Positive Non-Small Cell Lung Cancer
Black Diamond Therapeutics, Inc. recently announced the first patients dosed in mutation matched expansion cohorts of non-small cell lung cancer (NSCLC) in the ongoing Phase…
Immatics & Moderna Announce Strategic Multi-Platform Collaboration to Develop Innovative Oncology Therapeutics
Immatics, NV, and Moderna, Inc. recently announced a strategic research and development collaboration to pioneer novel and transformative therapies for cancer patients with high unmet….
Verona Pharma Announces FDA Has Accepted NDA Filing for Ensifentrine for the Maintenance Treatment of COPD
Verona Pharma plc recently announced the US FDA has accepted for review the company’s New Drug Application (NDA) seeking approval of ensifentrine for the maintenance…
MBX Biosciences Announces Positive Phase 1 Multiple Ascending Dose Data for Long-Acting Parathyroid Hormone Peptide Prodrug in Healthy Adults
MBX Biosciences, Inc. recently announced positive results from the multiple ascending dose (MAD) portion of the Phase 1 trial of MBX 2109, the company’s long-acting parathyroid…
WEBINAR - Impact of Process Re-design on Sustainability in Pharmaceutical Small Molecule Manufacturing
Join us for an upcoming webinar that delves into a crucial issue in the pharmaceutical industry. Recent research has revealed a surprising fact: the pharmaceutical sector has a larger carbon footprint than even the automotive industry, especially when we consider the entire supply chain’s impact on
Shape(TX) Collaborates With Otsuka to Develop Novel AAV Gene Therapies for Ocular Diseases
Shape(TX) and Otsuka Pharmaceutical Co., Ltd. recently announced a multi-target collaboration to develop intravitreally delivered adeno-associated viruses (AAVs) for ocular….
WEBINAR - Beyond the Lab: Unleashing the Potential of In Silico Modeling in Drug Product Formulation
In this webinar you will learn how digital chemistry tools facilitate rapid screening of formulation parameters, aiding in the identification of optimal drug delivery systems, excipient selection, and dosage forms….
The Evolving Role of a Contract Development & Manufacturing Organization
The meaning of a Contract Development and Manufacturing Organization (CDMO) is not the same as it was a decade ago. Customers today are seeking….
Valneva & Pfizer Report Positive Pediatric & Adolescent Phase 2 Booster Results for Lyme Disease Vaccine Candidate
Valneva SE and Pfizer Inc. recently announced positive pediatric and adolescent immunogenicity and safety data for their Lyme disease vaccine candidate, VLA15, when given….
Myricx Enters Antibody License Agreement With Biocytogen
Myricx Bio recently announced an antibody license agreement with Biocytogen Pharmaceuticals (Beijing) Co., Ltd, a global biotech company focusing on the….
Avextra Signs Distribution Agreements With Pharmaceutical Partners & Commences Exports of Cannabis-Based Medicines to Switzerland & Austria
Avextra AG recently announced the signing of three long-term supply and distribution agreements. Avextra has signed distribution agreements with two leading Swiss pharmaceutical partners and…
Artelo Biosciences Completes Positive Pre-IND Meeting With FDA
Artelo Biosciences, Inc. recently announced it has completed a pre-IND meeting with the US FDA regarding the manufacturing, preclinical, and clinical development plan for ART26.12.…
Antion Announces Granting of Key Technology Patent in the United States
Novel patent solidifies Antion’s position as an industry leader in multiplex engineering of cell and gene therapies….
Eledon Pharmaceuticals Announces Publication of Data Showing Treatment With Tegoprubart Promotes Kidney & Islet Allograft Survival & Function in Nonhuman Primates
Eledon Pharmaceuticals, Inc. recently announced the publication of a study evaluating tegoprubart as an immunomodulatory monotherapy in nonhuman primate kidney and islet allotransplants. The study,…
Palisade Bio Transforms GI-Focused Pipeline Through Exclusive Worldwide Licensing Agreement With Giiant Pharma for Multiple Oral Drug Candidates Targeting Inflammatory Bowel Disease
Palisade Bio, Inc. recently announced it has entered into a licensing agreement with Giiant Pharma, Inc., providing the company with the exclusive worldwide rights to develop, manufacture, and commercialize….
